Researchers at the University of Bath have developed innovative fluorescent molecular probes capable of tracking glucose changes within living animals, offering new insights into sugar metabolism and potential applications in disease diagnosis and treatment. Researchers at the University of Bath…
A new modelling study indicates that adopting England’s NHS diabetes prevention programme in Canada could slow the rise of type 2 diabetes and be cost-effective, especially with Indigenous-led adaptations in Ontario and Quebec. A publicly funded diabetes prevention programme modelled…
Research reveals that nearly one in six children aged 10 to 17 on GLP-1 drugs develop nutritional deficiencies within a year, urging better integration of dietary support into paediatric obesity and diabetes treatments. A new study in the journal Childhood…
Eli Lilly’s orforglipron claims a slight advantage over higher-dose oral semaglutide in weight loss and blood sugar reduction, signalling intensified competition in the race to develop effective oral GLP-1 therapies. Eli Lilly says its oral diabetes pill orforglipron has shown…
Eli Lilly’s initiative to deliver Mounjaro directly to patients’ homes prompts criticism from Australian doctors and pharmacists concerned over reduced clinical oversight and safety risks amid growing use of GLP-1 medications for diabetes and obesity. Eli Lilly’s plan to sell…
A new analysis presented at the European Association for the Study of Diabetes suggests that increasing the dose of semaglutide to 2 mg may offer better cardiovascular protection for adults with type 2 diabetes compared to switching to tirzepatide, raising…
New guidelines and recent trials position SGLT2 inhibitors such as dapagliflozin, empagliflozin, and canagliflozin as crucial for slowing chronic kidney disease progression, including in patients without diabetes, with safety considerations and lifestyle factors emphasised. SGLT2 inhibitors have moved from being…
Recent investigations highlight ferroptosis, an iron-dependent cell death process, as a key mechanism driving diabetic kidney disease progression. Experts suggest that targeting ferroptosis may open new therapeutic avenues beyond current treatments that slow but do not halt renal decline. A…
A Minnesota teacher’s experience with sudden blindness during pregnancy sheds light on the risks of diabetes-related eye damage and underscores the importance of regular screening for expectant women with diabetes. Kristin’s sudden blindness during her second pregnancy was not a…
Huawei claims it is close to launching a consumer device capable of measuring blood sugar non-invasively, marking a potential breakthrough in health tracking technology after years of research and patent filings suggesting multiple innovative approaches. Huawei says it is edging…
